- Not-So-Happy-Birthdays: Parties Helped Spread COVID, Study Finds
- In 11 States, Seniors’ Low Vaccination Rates a ‘Powder Keg’ for New Cases
- Health Highlights: June 21, 2021
- Survey Finds Many Adults Don’t Want Kids — and They’re Happy
- Screen All Kids for Heart Problems, Pediatricians’ Group Says
- New Genetic Insights Into Cause of ALS
- Drinking Rose During Pandemic, Especially for Women & Black Americans
- 5 Tests You Should Not Order for a Child With Autism
- Women, Take These Key Steps to Good Urological Health
- Sickle Cell Plagues Many Black Americans, But There’s Hope for Better Treatments
Generic Aciphex Approved to Treat Chronic Heartburn
FRIDAY, Nov. 8The first generic versions of the anti-GERD drug Aciphex (rabeprazole sodium) have been approved by the U.S. Food and Drug Administration for people aged 12 and older, the agency said Friday.
Gastroesophageal reflux disease (GERD), also known as chronic heartburn, is a very common disorder characterized by backward flow of stomach acid to the esophagus. This process could damage tissue in the esophagus, the tube that connects the throat and stomach.
License to produce generic rabeprazole was granted to Dr. Reddy’s Laboratories, Kremers Urban Pharmaceuticals, Lupin Pharmaceuticals, Mylan Pharmaceuticals, Teva Pharmaceuticals and Torrent Pharmaceuticals, the FDA said.
The drug is among a class called proton-pump inhibitors, which are designed to reduce the amount of stomach acid produced. Generic drugs, the FDA stressed, are equivalent to the brand-name versions in strength and quality.
More information
To learn more about GERD, visit Medline Plus.
Source: HealthDay
